How Much Does Compounded Semaglutide Cost in 2026?
Expect to pay $149-499/month for compounded semaglutide — often the cheapest semaglutide on the market and a sliver of brand-name Ozempic's $1,200+ cash price. We break down the real all-in numbers, why it's priced so low, and whether the cheaper route still beats brand-name savings programs once you do the math.
The Price Picture at a Glance
For two years the low monthly price made compounded semaglutide the budget on-ramp to GLP-1 therapy. That cost advantage is now being squeezed from every side. The end of the FDA shortage declaration, ongoing enforcement actions (including a March 2026 crackdown on 12 compounders), and the arrival of cheaper brand-name options are all narrowing the price gap that made compounded so appealing.
Why the Cheap Supply Is Shrinking
The FDA now considers the semaglutide shortage resolved, and that matters directly to your wallet. The shortage designation was the main legal hook that let compounding pharmacies mass-produce semaglutide without a patient-specific prescription — the very thing that kept prices low and supply plentiful. With the shortage lifted, that authority is sharply curtailed. A handful of 503B outsourcing facilities keep going under other rules, but enforcement is tightening. If you rely on a low monthly price from a compounder, plan for possible supply cuts and price out brand-name routes now rather than later.
What Each Semaglutide Route Costs Per Month
Figures below are typical out-of-pocket monthly prices as of April 2026. Your real number shifts with the provider you pick and your insurance status.
| Option | Monthly Cost | FDA Approved? | Quality Assurance | Availability Risk |
|---|---|---|---|---|
| Compounded Semaglutide | $149-499 | No | Variable (503B is best) | High (regulatory) |
| Brand Ozempic (cash) | $1,200+ | Yes | FDA-regulated | Low |
| Brand Ozempic (with savings) | $25-199 | Yes | FDA-regulated | Low |
| Oral Wegovy (50mg) | $149-590 | Yes | FDA-regulated | Low |
| Brand Wegovy (injection) | $1,350+ | Yes | FDA-regulated | Low |
What the Low Price Can Cost You: FDA Findings
Before you bank the savings, look at what the FDA has actually found. More than 50 warning letters have gone out to pharmacies compounding semaglutide, and these are not filing technicalities — they are quality-control failures that turn a cheap vial into a real health risk.
You May Not Get the Dose You Paid For
FDA lab testing has turned up compounded vials holding far more — or far less — semaglutide than the label claims. Pay for an under-strength vial and the drug simply will not deliver the results you bought it for. Pay for an over-strength one and you risk brutal gastrointestinal effects, low blood sugar, and other reactions. Brand-name product is verified to fall within 90-110% of labeled potency; the compounded vial you save money on comes with no such promise.
Contamination That Turns Cheap Into Expensive
Anything you inject has to be sterile — no bacteria, fungi, or endotoxins. FDA inspectors have documented compounders running substandard cleanrooms, flunking sterility tests, and shipping contaminated product. A single non-sterile injection can trigger anything from an irritated injection site to life-threatening sepsis, and a hospital bill erases any monthly savings many times over.
Paying for a Salt Form That Was Never Tested
Some compounders fill with semaglutide sodium rather than the semaglutide base used in Ozempic, and the FDA treats these as different substances. Semaglutide sodium has never gone through clinical trials, so how it is absorbed and cleared from the body is an open question. If that is what your low price buys, you are effectively paying for an untested drug.
Label Mistakes Where Precision Is Everything
Warning letters describe vials marked with the wrong concentration, no beyond-use date, and missing instructions — and in some cases the strength inside did not match the strength on the label. With a medication you titrate from 0.25mg up to 2.4mg over months, a labeling error is not a minor flaw; it is a dosing accident waiting to happen.
Telehealth Pricing:The Two Tiers You'll See
Nearly everyone buys compounded semaglutide through a telehealth platform that bundles the medication with a prescriber visit. Quotes swing widely based on your dose and what is folded into the price, but they tend to fall into two broad bands.
Lower Tier: $149-249/mo
This is the headline-grabbing band, usually tied to low doses (0.25mg-1mg) or a promotional first month. The $149 starter plans look great until your dose climbs and the monthly price climbs with it. The first telehealth visit is often included, but follow-up appointments can land on a separate bill.
Typical providers: Hims & Hers, Ro (introductory plans)
Higher Tier: $299-499/mo
Once you titrate up to full strength (1.7mg-2.4mg equivalent), you move into the premium band — provider visits, ongoing monitoring, and sometimes nutrition coaching baked in. At the top doses with full support, a few platforms push the monthly price all the way to $499.
Typical providers: Henry Meds, Calibrate, Found (full programs)
Watch the fine print: the number a provider advertises is rarely the number you pay. Ask whether it covers the drug, the consult, shipping, and any required labs. Plenty of platforms dangle a cheap medication price, then tack on consults ($50-100 each) and lab work ($100-200). The all-in monthly total is the only figure worth comparing.
Going Cheap Safely: A Buyer's Checklist
If brand-name is out of reach and the compounded price is the only one that works for your budget, these four checks help you spend that money more safely — they shrink the risk, though they cannot erase it.
Insist on a 503B Outsourcing Facility
503B facilities register with the FDA, get inspected, and have to follow current Good Manufacturing Practices (cGMP) — a far higher bar than the lightly supervised 503A pharmacies. Paying a little more for a 503B source buys you real oversight. Ask the provider to name and confirm their pharmacy's 503B registration before you order.
Confirm You're Buying Semaglutide Base
Ask point-blank whether the fill is semaglutide base or semaglutide sodium. Base is the form in Ozempic and Wegovy; sodium is a salt the FDA treats as a separate, never-clinically-studied substance. You do not want your low price quietly buying you the untested version.
Demand Batch Test Results
The better 503B facilities run independent potency and sterility testing on finished product. Ask for a certificate of analysis (CoA) showing your specific batch's tested potency. If a provider dodges the question or cannot produce one, treat that as a reason to walk — no matter how good the price looks.
Line Up a Brand-Name Fallback
With the rules tightening, your cheap supply could vanish on short notice. Price the brand-name savings routes today — the NovoCare PAP, manufacturer savings cards, and oral Wegovy can land surprisingly close to compounded numbers, so you are not scrambling if the compounded option disappears.
How Compounded Got So Cheap — And Why the Discount Is Fading
Between 2023 and 2025, compounded semaglutide went from niche to everywhere, and price was the engine. Demand for GLP-1 medication outran what Novo Nordisk could make, and once the FDA stamped semaglutide as being in shortage, compounding pharmacies were free to produce it at volume. That triggered a price war: hundreds of telehealth platforms spun up compounded programs, monthly costs collapsed to a fraction of the brand-name figure, and a huge cohort of patients who could never have stomached $1,200 a month suddenly had an affordable way in.
The discount era is closing. With the shortage officially declared over, the legal cover for mass compounding is gone and enforcement is picking up. Meanwhile the brand-name side keeps getting cheaper: oral Wegovy now opens at $149/month for the starting dose, NovoCare savings programs keep chipping away at out-of-pocket costs, and Medicare coverage widens in July 2026. Compounded semaglutide is not going to vanish next week, but the price advantage that defined it is eroding — so anyone leaning on it for the low cost should be mapping their brand-name exit now.
For a detailed comparison of compounded versus brand-name products, see our compounded vs. brand semaglutide guide.
Frequently Asked Questions
How much does compounded semaglutide cost per month?
Most patients pay between $149 and $499 a month, with the all-in figure depending on your dose, the provider, and whether the consultation and shipping are bundled into the quoted price. Low starting doses (0.25mg-1mg) tend to land at the bottom of that band, while full-dose plans with monitoring sit at the top. Compare that to roughly $1,200+ a month for brand-name Ozempic paid in cash without insurance, and you can see why compounded became the budget route for so many people.
Is compounded semaglutide the cheapest way to get semaglutide?
On sticker price alone, yes — compounded semaglutide is usually the cheapest semaglutide you can buy, often a quarter or less of the brand-name cash cost. But cheapest on paper is not always cheapest in practice. Oral Wegovy now starts at $149/month, and a NovoCare savings card or patient-assistance program can pull brand-name Ozempic down to $25-$199 for some people. Run the all-in math for your own situation before assuming compounded wins on price.
Why is compounded semaglutide priced so far below Ozempic?
The gap comes down to what is baked into each price. Compounding pharmacies skip the things that inflate a branded medication: they did not fund Novo Nordisk's research, they do not run multi-year clinical trials or pursue FDA approval of a finished product, and they spend almost nothing on advertising. The semaglutide peptide itself is cheap to make. So the branded markup is largely paying for development, regulation, and marketing — not the molecule.
Is the lower price worth the safety trade-off?
That is the real question behind the cost. Saving money is only a saving if the product works and is safe. The FDA has sent more than 50 warning letters to compounders over wrong dosing, bacterial or endotoxin contamination, sterility failures in injectables, and untested semaglutide salt forms — and these have led to documented harm, not just paperwork. A cheaper vial that under-doses you or sends you to the ER is not a bargain. Weigh the price against the quality assurance you give up.
Does the semaglutide form affect what I'm paying for?
It can, and it is worth asking before you pay. Some pharmacies fill prescriptions with semaglutide sodium, a salt form the FDA treats as a different substance that has never been clinically studied, rather than the semaglutide base used in Ozempic and Wegovy. If your low price is buying a salt form, you may be paying for something that absorbs differently or works less predictably. Confirm you are getting semaglutide base for your money.
Which telehealth providers have the cheapest compounded semaglutide?
Platforms that have offered compounded semaglutide include Hims & Hers, Ro, Henry Meds, and a long tail of smaller services, with monthly prices spanning $149 to $499 depending on dose and what is bundled. The lowest advertised number is not always the lowest real cost — some add consult fees ($50-$100) and labs ($100-$200) on top. Availability is also shrinking as enforcement ramps up, so factor in supply risk, not just price, and confirm the source is a 503B-registered facility.
Will switching to brand-name actually cost me more?
Not necessarily — and that is the surprise for a lot of patients. If you have insurance coverage, a manufacturer savings card, or qualify for the NovoCare patient-assistance program, brand-name Ozempic can land in the same range as compounded, sometimes cheaper, with full FDA quality control and no compounding-related risk. Before you stick with compounded purely to save money, price out the brand-name savings routes; the cost gap may be smaller than you think.
Find Your Actual Cheapest Route
Compounded is one price on the menu, not the whole menu. Brand-name savings cards, oral semaglutide, and a sharper look at your insurance can land you near the same monthly number — with FDA quality control thrown in.
Disclaimer: This content is for educational purposes only and does not constitute medical or legal advice. Compounded medications carry risks that FDA-approved products do not. The regulatory status of compounded semaglutide is evolving — verify current legal status before purchasing. Always discuss medication decisions with your prescriber. GLP-1 Price Tracker is not affiliated with any compounding pharmacy, telehealth provider, or pharmaceutical company.